| Dr Nadine Clair Straka, MB BCH BAO LRCP | |
|
300 Longwood Ave, Bch Hunnewell Building Pavilion 129, Housestaff Lounge, Boston, MA 02115-5724 | |
| (617) 355-8241 | |
| Not Available |
| Full Name | Dr Nadine Clair Straka |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Critical Care Medicine |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013397603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0203X | Pediatrics - Pediatric Critical Care Medicine | 274268 (Massachusetts) | Primary |
| Entity Name | Chmc Anesthesia Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831268754 PECOS PAC ID: 0446155568 Enrollment ID: O20031203000162 |
News Archive
Inoperable malignant pleural mesothelioma, is a rare and aggressive cancer of the protective lining of the lungs, or pleura, often caused by exposure to asbestos.
Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs - the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
The Children's Hospital of Philadelphia today launched the Fetal Neuroprotection and Neuroplasticity Program. Building on growing evidence of the interaction of heart disease and brain development in the fetus, this Program will systematically investigate innovative therapies to protect brain development and to prevent brain injury as early as possible before birth.
Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.
Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.
› Verified 8 days ago
| Entity Name | Boston Childrens Heart Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982680922 PECOS PAC ID: 8729071675 Enrollment ID: O20040406001030 |
News Archive
Inoperable malignant pleural mesothelioma, is a rare and aggressive cancer of the protective lining of the lungs, or pleura, often caused by exposure to asbestos.
Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs - the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
The Children's Hospital of Philadelphia today launched the Fetal Neuroprotection and Neuroplasticity Program. Building on growing evidence of the interaction of heart disease and brain development in the fetus, this Program will systematically investigate innovative therapies to protect brain development and to prevent brain injury as early as possible before birth.
Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.
Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.
› Verified 8 days ago
| Entity Name | Children's Hospital Pediatric Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306664 PECOS PAC ID: 3476541830 Enrollment ID: O20040504000964 |
News Archive
Inoperable malignant pleural mesothelioma, is a rare and aggressive cancer of the protective lining of the lungs, or pleura, often caused by exposure to asbestos.
Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs - the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
The Children's Hospital of Philadelphia today launched the Fetal Neuroprotection and Neuroplasticity Program. Building on growing evidence of the interaction of heart disease and brain development in the fetus, this Program will systematically investigate innovative therapies to protect brain development and to prevent brain injury as early as possible before birth.
Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.
Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.
› Verified 8 days ago
| Entity Name | Chmc Anesthesia Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831268754 PECOS PAC ID: 0446155568 Enrollment ID: O20050920000649 |
News Archive
Inoperable malignant pleural mesothelioma, is a rare and aggressive cancer of the protective lining of the lungs, or pleura, often caused by exposure to asbestos.
Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs - the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
The Children's Hospital of Philadelphia today launched the Fetal Neuroprotection and Neuroplasticity Program. Building on growing evidence of the interaction of heart disease and brain development in the fetus, this Program will systematically investigate innovative therapies to protect brain development and to prevent brain injury as early as possible before birth.
Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.
Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nadine Clair Straka, MB BCH BAO LRCP 300 Longwood Ave, Boston, MA 02115-5724 Ph: () - | Dr Nadine Clair Straka, MB BCH BAO LRCP 300 Longwood Ave, Bch Hunnewell Building Pavilion 129, Housestaff Lounge, Boston, MA 02115-5724 Ph: (617) 355-8241 |
News Archive
Inoperable malignant pleural mesothelioma, is a rare and aggressive cancer of the protective lining of the lungs, or pleura, often caused by exposure to asbestos.
Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs - the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
The Children's Hospital of Philadelphia today launched the Fetal Neuroprotection and Neuroplasticity Program. Building on growing evidence of the interaction of heart disease and brain development in the fetus, this Program will systematically investigate innovative therapies to protect brain development and to prevent brain injury as early as possible before birth.
Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.
Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.
› Verified 8 days ago
Puja Banka, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Bader 203, Boston, MA 02115 Phone: 617-355-6363 | |
Angela M. Jacques, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Phone: 617-726-2066 | |
Dr. Elizabeth Susan Taglauer, M.D., PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Cailyn Hereen Rood, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Dr. Alon Peltz, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Miki Nishitani, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Vickren Pillay, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 |